Inspired by Science
Our R&D pipeline consists of several innovative programs.We work hard to develop future therapeutics to combat neurodegeneration in diseases like Alzheimer’s, Parkinson’s and Amyotrophic lateral sclerosis. More recently we have expanded our core therapeutic areas to include also oncology.
Read more about Research and Development...
Commercial Success
Medeia leverages early partnerships with global biotech and pharma companies to advance products discovered by Medeia to clinical trials. Medeia presents a number of interesting business opportunities.
Read more about Business Development...
-
2012-03-20Kuopio, Finland
Medeia Therapeutics Ltd succeeded in Young Innovative Company program and is eligible for funding totalling EUR 1.7 million
Read more... -
2010-02-17Kuopio, Finland
Medeia Therapeutics Ltd has been awarded a 0,65 million euro grant from Young Innovative Company (YIC) program financed by Tekes.
Read more... -
2009-01-27Kuopio, Finland
Medeia Therapeutics receives significant support from Finnish Funding Agency for Technology and Innovation (Tekes)
Read more...